🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ICYMI If you want to produce a multi-omic map of a diseased tissue/organ, a 3D assessment is not simply a nice thing to do, it is the only way. One or two TMA cores or whole slides are insufficient, always. See more here: biorxiv.org/content/10.110… CODA: pubmed.ncbi.nlm.nih.gov/36747709/

This work extends previous studies demonstrating importance of the TME, specifically the macrophage, in outcome of Hodgkin lymphoma; future studies should leverage the assay to determine whether this represents a predictive biomarker. Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Intresting short article in Nature Medicine discussing the decline in clinical academics in the UK and US. Another issue, not discussed, is the failure to recognise all the components of the job equally, clinical/research/teaching. The interests of Universities and the NHS are

We used #GPT4 to greatly simplify medical consent forms for patients in new NEJM AI paper ai.nejm.org/stoken/default… Our #LLM simplified forms are now used in the largest health system in Rhode Island. Medical documents like consent forms are often hard to understand--great use

A few thoughts on the recent comparison paper for imaging-based #spatialtranscriptomics (iST) methods from the Rahul Satija: biorxiv.org/content/10.110…

🔬 Have a look at the significant advances Cedars-Sinai Cancer has achieved in enhancing cancer treatment and care. Cancer at Cedars-Sinai ceda.rs/3So1TrK

Dr. Akil Merchant Akil Merchant is co-senior author on a Journal of Clinical Oncology paper using innovative #spatialprofiling techniques to predict if #cancer of the immune system recurs in patients treated with a #bonemarrowtransplant. Journal of Clinical Oncology cedars-sinai.org/newsroom/predi…

Happy to share our latest paper by Omar S.M. El Nahhas et al., which was just published in Nature Communications! This work presents a new method which improves the prediction of biomarkers from routine pathology slides. nature.com/articles/s4146… TU Dresden katherlab @Medizin_TUD

Save the Date📝: The Cedars-Sinai Spatial Biology Symposium will take place on March 7, focusing on Cancer, Stem Cells & Development, and Neuroscience. RSVP for in-person attendance and submit a trainee lightning talk abstract here: forms.office.com/r/8tEaZ1ZT8N

Hello spatial bio folks! Happy to announce the 2nd Annual Cedars-Sinai Spatial Biology Symposium, next Thursday March 7! RSVP to join us in LA in person or virtually, for spatial this, spatial that, and all the spatial others! forms.office.com/r/8tEaZ1ZT8N

We used IMC to look at primary, metastatic, recurrent ovarian cancer - an understudied cancer overall but tissue is widely available. Side note, published panels are years behind. Can’t speak for all but in this study of ours at least, we can and are doing much better.

Cell Simulation as Cell Segmentation biorxiv.org/content/10.110…

Are you looking for a PhD program in health AI embedded in a top US hospital with access to clinical data & physicians? Check out our new PhD program at Cedars-Sinai Medical Center in LA cedars-sinai.edu/education/grad… #phd #artificialintelligence #Bioinformatics

Earlier this week we carried out a preliminary analysis of our first 10x Genomics Xenium prime (5,000 gene) run. We had designed this experiment to get a sense of how the prime chemistry performed compared to the Xenium V1 chemistry.

Presenting an overview with Ranjana Advani of the current role of brentuximab and the checkpoint inhibitors in classic Hodgkin lymphoma: doi.org/10.1200/OP.24.… Thanks to JCO Oncology Practice for a great review & publication process.

Concluding the 2024 Research Updates in Lymphoma with a Lunch Time Round Table on Major Knowledge Gaps and Research Opportunities in Transformed Lymphoma. Thank you to our dedicated faculty and attendees, both in-person and virtual, for making this a successful event!

Excited to share that the 2024 Research Updates in Lymphoma was a fantastic success! We enjoyed excellent presentations, insightful discussions, and explored novel techniques and future research opportunities in #lymphoma transformation. Akil Merchant Ash Alizadeh, MD/PhD 🇺🇸

Thank you to everyone who joined us for the 2024 Research Updates in Lymphoma conference at Cedars-Sinai on Sept 28-29! We appreciate the national experts who shared their insights on cutting-edge treatments and groundbreaking research in lymphoma care. #LymphomaResearch

Cedars-Sinai Establishes Health Sciences University including new PhD Program in Health Artificial Intelligence! Please RT! cedars-sinai.org/newsroom/cedar… #artificialintelligence

Hey Elon Musk and Vivek Ramaswamy, single payer health care is clearly the most efficient. Love to see DOGE promote that. Time to cut out the insurance companies and pharmacy benefit managers who just suck money and effort out of the system.